Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus neurotoxins

US Patent 6713444 · Granted Mar 30, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Large-scale production of human serum butyrylcholinesterase as a bioscavenger2010
Liposomes containing novel targeting and/or fusogenic peptides, preparations con2010
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and 2008
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and 2008
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and 2008
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and 2007
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and 2007
Previns as specific inhibitors and therapeutic agents for botulinum toxin B and 2007
Assay for detecting, measuring and monitoring the activities and concentrations 2004
Assay for detecting, measuring and monitoring the activities and concentrations 2004
Preparation of enzymatically active sponges or foams for detoxification of hazar2003
Preparation of enzymatically active sponges or foams for detoxification of hazar2003